Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03940950 · ClinicalTrials.gov registry record · Phase 1
Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee
A Phase 1 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
NCT03940950: Completed Phase 1 study, sponsored by Mayo Clinic.
NCT03940950 is a Phase 1 study that has completed, run by Mayo Clinic. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03940950, a Phase 1 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
Study Summary
Researchers are trying to determine the safety and feasibility of autologous, adipose derived stromal vascular fraction injections in the treatment of knee osteoarthritis
Interventions
- DRUG Placebo
- BIOLOGICAL Autologous Adipose-Derived SVF (Stromal Vascular Fraction)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-07-02 |
| Est. Completion | 2025-05-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03940950
The ClinicalTrials.gov registry entry for NCT03940950 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03940950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03940950 about?
NCT03940950 is a clinical study titled "Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Faction (SVF) for Treatment of Osteoarthritis of the Knee". Researchers are trying to determine the safety and feasibility of autologous, adipose derived stromal vascular fraction injections in the treatment of knee osteoarthritis
What is the current status of trial NCT03940950?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2019-07-02. Estimated completion is 2025-05-23.
What interventions are being tested in trial NCT03940950?
The interventions under investigation include: Placebo (DRUG), Autologous Adipose-Derived SVF (Stromal Vascular Fraction) (BIOLOGICAL).
Who is sponsoring clinical trial NCT03940950?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.